PMC:7200337 / 83523-83746 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T482","span":{"begin":52,"end":60},"obj":"Disease"}],"attributes":[{"id":"A482","pred":"mondo_id","subj":"T482","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"An ongoing double-blind RCT of patients with severe COVID-19 (NCT04323527) randomized 81 patients into high-dose HCQ (600 mg 2× per day for 10 days) or low-dose (450 mg/day for 5 days) treatment groups (Borba et al., 2020)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"2760","span":{"begin":31,"end":39},"obj":"Species"},{"id":"2761","span":{"begin":89,"end":97},"obj":"Species"},{"id":"2766","span":{"begin":113,"end":116},"obj":"Chemical"},{"id":"2770","span":{"begin":52,"end":60},"obj":"Disease"}],"attributes":[{"id":"A2760","pred":"tao:has_database_id","subj":"2760","obj":"Tax:9606"},{"id":"A2761","pred":"tao:has_database_id","subj":"2761","obj":"Tax:9606"},{"id":"A2766","pred":"tao:has_database_id","subj":"2766","obj":"MESH:D006886"},{"id":"A2770","pred":"tao:has_database_id","subj":"2770","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"An ongoing double-blind RCT of patients with severe COVID-19 (NCT04323527) randomized 81 patients into high-dose HCQ (600 mg 2× per day for 10 days) or low-dose (450 mg/day for 5 days) treatment groups (Borba et al., 2020)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T475","span":{"begin":0,"end":223},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"An ongoing double-blind RCT of patients with severe COVID-19 (NCT04323527) randomized 81 patients into high-dose HCQ (600 mg 2× per day for 10 days) or low-dose (450 mg/day for 5 days) treatment groups (Borba et al., 2020)."}